Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

BACKGROUND: Therapeutic drug monitoring (TDM) aid therapeutic decision making in patients with inflammatory bowel disease (IBD) who lose response to anti-TNF therapy. Our aim was to evaluate the frequency and predictive factors of loss of response (LOR) to adalimumab using TDM in IBD patients. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonczi, Lorant, Kurti, Zsuzsanna, Rutka, Mariann, Vegh, Zsuzsanna, Farkas, Klaudia, Lovasz, Barbara D., Golovics, Petra A., Gecse, Krisztina B., Szalay, Balazs, Molnar, Tamas, Lakatos, Peter L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549364/
https://www.ncbi.nlm.nih.gov/pubmed/28789636
http://dx.doi.org/10.1186/s12876-017-0654-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549364/
https://www.ncbi.nlm.nih.gov/pubmed/28789636
http://dx.doi.org/10.1186/s12876-017-0654-1

Ejemplares similares